Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

More Frequent HCFA Payment, Coding Adjustments Called For In Ramstad Bill

This article was originally published in The Gray Sheet

Executive Summary

The Health Care Financing Administration would be required to adjust Medicare's payment systems annually in order to accommodate changes in medical technology, under legislation (HR 2030) introduced June 7 by Rep. Jim Ramstad (R-Minn.).

You may also be interested in...



Exogen Avoids Lengthy MCAC Process In HCFA Coverage Review

The Health Care Financing Administration plans to develop a national Medicare coverage decision for Exogen's Sonic Accelerated Fracture Healing System (SAFHS) without bringing the issue before the Medicare Coverage Advisory Committee, agency staffers report.

Exogen Avoids Lengthy MCAC Process In HCFA Coverage Review

The Health Care Financing Administration plans to develop a national Medicare coverage decision for Exogen's Sonic Accelerated Fracture Healing System (SAFHS) without bringing the issue before the Medicare Coverage Advisory Committee, agency staffers report.

Lab Test Payment Language Added To Medicare Technology Access Bill

Diagnostic test manufacturers would be able to request administrative review and revision of adverse coding and payment policy determinations for products covered by Medicare, under legislation (HR 4395) introduced May 10 by Reps. Jim Ramstad (R-Minn.) and Karen Thurman (D-Fla.).

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT011914

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel